Search Results

There are 7430800 results for: content related to: Safety and efficacy of arsenic trioxide for patients with advanced metastatic melanoma

  1. Apoptosis in arsenic trioxide-treated Calu-6 lung cells is correlated with the depletion of GSH levels rather than the changes of ROS levels

    Journal of Cellular Biochemistry

    Volume 104, Issue 3, 1 June 2008, Pages: 862–878, Yong Hwan Han, Suhn Hee Kim, Sung Zoo Kim and Woo Hyun Park

    Version of Record online : 7 APR 2008, DOI: 10.1002/jcb.21673

  2. You have free access to this content
    Synergistic anticancer effects of arsenic trioxide with bortezomib in mantle cell lymphoma

    American Journal of Hematology

    Volume 87, Issue 12, December 2012, Pages: 1057–1064, Hyun Joo Jung, Zheng Chen and Nami McCarty

    Version of Record online : 11 SEP 2012, DOI: 10.1002/ajh.23317

  3. Program outline for Melanoma Congress Program – November 1–4, 2007

    Pigment Cell Research

    Volume 20, Issue 6, December 2007, Pages: 513–580,

    Version of Record online : 9 OCT 2008, DOI: 10.1111/j.1600-0749.2007.00416_2.x

  4. Tumor growth inhibition of metastatic nasopharyngeal carcinoma cell lines by low dose of arsenic trioxide via alteration of cell cycle progression and induction of apoptosis

    Head & Neck

    Volume 33, Issue 5, May 2011, Pages: 734–742, Kun-Yun Yeh, John W.-C. Chang, Ying-Ying Li, Cheng-Hsu Wang and Hung-Ming Wang

    Version of Record online : 24 AUG 2010, DOI: 10.1002/hed.21535

  5. You have free access to this content
    A phase II trial of arsenic trioxide in patients with metastatic melanoma


    Volume 104, Issue 8, 15 October 2005, Pages: 1687–1692, Kevin B. Kim, Agop Y. Bedikian, Luis H. Camacho, Nicholas E. Papadopoulos and Cecilia McCullough

    Version of Record online : 29 AUG 2005, DOI: 10.1002/cncr.21386

  6. Intracellular GSH level is a factor in As4.1 juxtaglomerular cell death by arsenic trioxide

    Journal of Cellular Biochemistry

    Volume 104, Issue 3, 1 June 2008, Pages: 995–1009, Yong Hwan Han, Sung Zoo Kim, Suhn Hee Kim and Woo Hyun Park

    Version of Record online : 4 FEB 2008, DOI: 10.1002/jcb.21685

  7. You have free access to this content
    Long-term efficacy and safety of arsenic trioxide for first-line treatment of elderly patients with newly diagnosed acute promyelocytic leukemia


    Volume 119, Issue 1, 1 January 2013, Pages: 115–125, Yingmei Zhang, Zhuo Zhang, Jinmei Li, Limin Li, Xueying Han, Lina Han, Longhu Hu, Shuye Wang, Yanhong Zhao, Xiaoxia Li, Ying Zhang, Shengjin Fan, Chengfang Lv, Yinghua Li, Yanhua Su, Hui Zhao, Xin Zhang and Jin Zhou

    Version of Record online : 28 AUG 2012, DOI: 10.1002/cncr.27650

  8. You have free access to this content
    Genistein selectively potentiates arsenic trioxide-induced apoptosis in human leukemia cells via reactive oxygen species generation and activation of reactive oxygen species-inducible protein kinases (p38-MAPK, AMPK)

    International Journal of Cancer

    Volume 123, Issue 5, 1 September 2008, Pages: 1205–1214, Yolanda Sánchez, Donna Amrán, Carlos Fernández, Elena de Blas and Patricio Aller

    Version of Record online : 10 JUN 2008, DOI: 10.1002/ijc.23639

  9. You have free access to this content
    Cbl-b-dependent degradation of FLIPL is involved in ATO-induced autophagy in leukemic K562 and gastric cancer cells

    FEBS Letters

    Volume 586, Issue 19, September 21, 2012, Pages: 3104–3110, Guodong Zhang, Jing Liu, Ye Zhang, Jinglei Qu, Ling Xu, Huachuan Zheng, Yunpeng Liu and Xiujuan Qu

    Version of Record online : 1 AUG 2012, DOI: 10.1016/j.febslet.2012.07.067

  10. You have full text access to this OnlineOpen article
    Arsenic trioxide rewires mantle cell lymphoma response to bortezomib

    Cancer Medicine

    Volume 4, Issue 11, November 2015, Pages: 1754–1766, Ling-Ling Zhao, Yuan-Fang Liu, Li-Jun Peng, Ai-Mei Fei, Wen Cui, Sheng-Chao Miao, Olivier Hermine, Remy Gressin, Saadi Khochbin, Sai-Juan Chen, Jin Wang and Jian-Qing Mi

    Version of Record online : 26 AUG 2015, DOI: 10.1002/cam4.511

  11. You have full text access to this Open Access content
    Arsenic trioxide prevents nitric oxide production in lipopolysaccharide -stimulated RAW 264.7 by inhibiting a TRIF-dependent pathway

    Cancer Science

    Volume 104, Issue 2, February 2013, Pages: 165–170, Miyuki Takahashi, Akinobu Ota, Sivasundaram Karnan, Ekhtear Hossain, Yuko Konishi, Lkhagvasuren Damdindorj, Hiroyuki Konishi, Takashi Yokochi, Masakazu Nitta and Yoshitaka Hosokawa

    Version of Record online : 13 DEC 2012, DOI: 10.1111/cas.12053

  12. Dose-adjusted arsenic trioxide for acute promyelocytic leukaemia in chronic renal failure

    European Journal of Haematology

    Volume 95, Issue 4, October 2015, Pages: 331–335, Frank Firkin, Fernando Roncolato and Wai Khoon Ho

    Version of Record online : 23 MAR 2015, DOI: 10.1111/ejh.12502

  13. You have free access to this content
    Phase 1 study of arsenic trioxide, high-dose cytarabine, and idarubicin to down-regulate constitutive signal transducer and activator of transcription 3 activity in patients aged <60 years with acute myeloid leukemia


    Volume 117, Issue 21, 1 November 2011, Pages: 4831–4868, Meir Wetzler, Chris Andrews, Laurie A. Ford, Sheila Tighe, Maurice Barcos, Sheila N. J. Sait, AnneMarie W. Block, Norma J. Nowak, Maria R. Baer, Eunice S. Wang and Heinz Baumann

    Version of Record online : 31 MAR 2011, DOI: 10.1002/cncr.26097

  14. You have free access to this content
    Arsenic trioxide inhibits tumor cell growth in malignant rhabdoid tumors in vitro and in vivo by targeting overexpressed Gli1

    International Journal of Cancer

    Volume 135, Issue 4, 15 August 2014, Pages: 989–995, Kornelius Kerl, Natalia Moreno, Till Holsten, Julia Ahlfeld, Julius Mertins, Marc Hotfilder, Marcel Kool, Kerstin Bartelheim, Sabine Schleicher, Rupert Handgretinger, Ulrich Schüller, Michael Meisterernst and Michael C. Frühwald

    Version of Record online : 25 JAN 2014, DOI: 10.1002/ijc.28719

  15. Aberrant overexpression of FOXM1 transcription factor plays a critical role in lung carcinogenesis induced by low doses of arsenic

    Molecular Carcinogenesis

    Volume 53, Issue 5, May 2014, Pages: 380–391, Youhong Liu, Janet M. Hock, Rebecca J. Van Beneden and Xiong Li

    Version of Record online : 19 DEC 2012, DOI: 10.1002/mc.21989

  16. You have free access to this content
    Outcome of therapy-related acute promyelocytic leukemia with or without arsenic trioxide as a component of frontline therapy


    Volume 117, Issue 1, 1 January 2011, Pages: 110–115, Farshid Dayyani, Hagop Kantarjian, Susan O'Brien, Sherry Pierce, Dan Jones, Stefan Faderl, Guillermo Garcia-Manero, Jorge Cortes and Farhad Ravandi

    Version of Record online : 27 AUG 2010, DOI: 10.1002/cncr.25585

  17. You have free access to this content
    Phase II study of arsenic trioxide and ascorbic acid for relapsed or refractory lymphoid malignancies: a Wisconsin Oncology Network study

    Hematological Oncology

    Volume 27, Issue 1, March 2009, Pages: 11–16, JE Chang, PM Voorhees, JM Kolesar, HG Ahuja, FA Sanchez, GA Rodriguez, K Kim, J Werndli, HH Bailey and BS Kahl

    Version of Record online : 31 JUL 2008, DOI: 10.1002/hon.870

  18. Environmentally relevant concentration of arsenic trioxide and humic acid promoted tumor progression of human cervical cancer cells: In vivo and in vitro studies

    Environmental Toxicology

    Volume 31, Issue 9, September 2016, Pages: 1121–1132, Min-Ling Tsai, Cheng-Chieh Yen, Fung-Jou Lu, Hung-Chih Ting and Horng-Rong Chang

    Version of Record online : 2 MAR 2015, DOI: 10.1002/tox.22121

  19. You have free access to this content
    A phase 2 trial of combination therapy with thalidomide, arsenic trioxide, dexamethasone, and ascorbic acid (TADA) in patients with overlap myelodysplastic/myeloproliferative neoplasms (MDS/MPN) or primary myelofibrosis (PMF)


    Volume 118, Issue 16, 15 August 2012, Pages: 3968–3976, Nelli Bejanyan, Ramon V. Tiu, Azra Raza, Ania Jankowska, Matt Kalaycio, Anjali Advani, Josephine Chan, Yogen Saunthararajah, Lindsey Mooney, Jaroslaw P. Maciejewski and Mikkael A. Sekeres

    Version of Record online : 16 DEC 2011, DOI: 10.1002/cncr.26741

  20. Economic evaluation of arsenic trioxide compared to all-trans retinoic acid + conventional chemotherapy for treatment of relapsed acute promyelocytic leukemia in Canada

    European Journal of Haematology

    Volume 95, Issue 3, September 2015, Pages: 218–229, Jean Lachaine, Karine Mathurin, Stéphane Barakat and Stephen Couban

    Version of Record online : 4 FEB 2015, DOI: 10.1111/ejh.12475